Dominique ten Haaf and colleagues performed a randomized clinical trial to assess the effects of 12-weeks protein supplementation on body characteristics. Daily supplementation of 30 grams of protein increased lean body mass and reduced fat mass. Findings were published in the Journal of Cachexia, Sarcopenia & Muscle.Sufficient protein intake is important for the maintenance of muscle mass. However, Ten Haaf previously showed that 63% of physically active individuals aged >65 years have insufficient protein consumption. In the present study, the effects of protein supplementation on muscle mass, muscle strength and physical performance were assessed.
A total of 116 physically active older adults with insufficient protein intake and preparing for the Nijmegen Marches were recruited and allocated to daily protein supplementation or placebo. Measurements of body composition, muscle strength and physical performance were performed before the start and after 12 weeks of supplementation. Participants receiving proteins demonstrated a larger increase in relative lean body mass and larger reduction in fat mass during the study. No differences in muscle strength or physical performance were observed most likely because both groups already performed extremely well on these parameters at the initiation of the study.
Findings from the present study provide important insight in strategies to optimize the health benefits of a physically active lifestyle in older adults. Increasing or maintaining lean body mass is important as 0.5-1% of muscle mass is typically lost per year due to ageing. Preservation of muscle mass and muscle strength are important prerequisites to preserve mobility and independence for daily life activities while ageing.
Protein supplementation improves lean body mass in physically active older adults: a randomized placebo-controlled trial.
Ten Haaf DSM, Eijsvogels TMH, Bongers CCWG, Horstman AMH, Timmers S, de Groot LCPGM, Hopman MTE.
Dominique ten Haaf is member of theme Vascular damage.
Related news items
Hans van Bokhoven newly elected in Academia Europaea22 August 2019
The Academia Europaea is a functioning European Academy of Humanities, Letters and Sciences, composed of individual members.read more
Drug-induced interstitial lung disease in advanced breast cancer patients receiving everolimus22 August 2019
In Targeted Oncology, Annelieke Willemsen, Carla van Herpen and colleagues, showed that pulmonary function test with diffusion capacity of the lungs for carbon monoxide and serum biomarkers can be of aid to differentiate everolimus-related interstitial lung disease from other respiratory problems.read more
Publication in PNAS on dissecting EEC syndrome using single-cell RNA-seq22 August 2019
PhD candidates Eduardo Soares and Quan Xu in Jo Huiqing Zhou’s group in Molecular Developmental Biology, theme Reconstruction and regenerative medicine, have published a paper in PNAS on the disease mechanism of EEC syndrome using single-cell RNA-seq technology and patient-derived iPSCs.read more
Patient trust and participation in cell biological research21 August 2019
Alessandra Cambi and Gert Olthuis, discuss key ethical issues inherent in the development and the value of building trust and trustworthiness.read more
NWO grant for a tissue-generating patch to close diaphragmatic defects21 August 2019
Willeke Daamen and Toin van Kuppevelt, theme Reconstructive and regenerative medicine, were recently awarded a 690 k€ grant by NWO, domain Applied & Engineering Sciences, for the development of advanced patches for closure of diaphragmatic defects in children with congenital diaphragmatic hernia.read more
Front cover Human Mutation21 August 2019
The MetaDome web server build to interpret genetic variants based on genetic tolerance and homologous protein domains is featured on the Cover of Human Mutation. MetaDome was developed by Laurens van de Wiel, Coos Baakman, Daan Gilissen, Joris Veltman, Gert Vriend and Christian Gilissen,read more